Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages

Andreas Dander, Matthias Baldauf, Michael Sperk

  • 1Division for Bioinformatics, Biocenter, Innsbruck Medical University, Innrain 80-82, 6020 Innsbruck, Austria. zlatko.trajanoski@i-med.ac.at.

BMC Bioinformatics
|September 19, 2014
PubMed
Abstract

Insights

A new bioinformatics platform, Personalized Oncology Suite (POS), integrates clinical, next-generation sequencing (NGS), and whole-slide bioimage data for personalized cancer immunotherapy research. This open-source tool enhances data analysis for oncology studies.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Oncology

Background:

  • Cancer immunotherapy has advanced significantly with new treatments showing promising results.
  • Technological progress in next-generation sequencing (NGS) and whole-slide bioimaging enables personalized cancer therapies.
  • A gap exists in bioinformatics solutions for integrating diverse datasets like clinical, genomic, and imaging data.

Purpose of the Study:

  • To develop a bioinformatics platform for integrating heterogeneous cancer-related datasets.
  • To create a solution supporting personalized cancer immunotherapy development.
  • To provide a flexible and expandable platform for clinical researchers.

Main Methods:

  • Development of the Personalized Oncology Suite (POS), a web-based bioinformatics platform.
  • Implementation of a data warehouse schema for integrating clinical, NGS (SNPs, INDELs), and whole-slide bioimages.
  • Inclusion of a genome browser and bioimage management application (Bisque).

Main Results:

  • POS successfully integrates clinical, genomic, and imaging data into a unified platform.
  • The platform offers visualization tools, data upload/download capabilities, and a modular architecture.
  • POS is scalable, flexible, and expandable for community modification and extension.

Conclusions:

  • Web-based integration of clinical, NGS, and imaging data is a valuable resource for oncology research.
  • POS supports personalized cancer immunotherapy and other studies involving NGS and tissue imaging.
  • The open-source POS platform is available for download and further development.